U.S. Markets open in 8 hrs 54 mins

'Pharma bro' Martin Shkreli sues Retrophin directors, ex-general counsel for more than $30 million from prison in Pennsylvania

Dan Mangan

Notorious 'pharma bro' Martin Shkreli is sued two directors and the ex-general counsel of his former biopharmaceutical company Retrophin for more than $30 million, accusing them of using fraud to oust him as head of the firm in 2014. It was lodged within days of him being transferred to a new prison in Pennsylvania, where he will continue serving a seven-year sentence for securities fraud related to Retrophin and two hedge funds, which financially collapsed under his operation. Shkreli gained national infamy in 2015 after his Turing Pharmaceuticals, now known as Phoenixus AG, hiked the price of its drug Daraprim by more than 5,000%.